A compass that points to lupus: genetic studies on type I interferon pathway
- PMID: 17581625
- DOI: 10.1038/sj.gene.6364409
A compass that points to lupus: genetic studies on type I interferon pathway
Abstract
It was more than 20 years ago that patients with systemic lupus erythematosus (SLE) were first reported to display elevated serum levels of type I interferon (IFN). Since then, extensive studies revealed a crucial role for type I IFN in SLE pathogenesis. The current model proposes that small increase of type I IFN production by plasmacytoid dendritic cells (pDCs) is sufficient to induce unabated activation of immature peripheral DCs. IFN-matured DCs select and activate autoreactive T cells and B cells, rather than deleting them, resulting in peripheral tolerance breakdown, a characteristic feature of SLE. Furthermore, immune complexes provide an amplification loop to pDCs for further IFN production. In the past 5 years, high-throughput technologies such as expression profiling and single-nucleotide polymorphism (SNP) typing established the role of altered type I IFN system in SLE, and a detailed picture of its molecular mechanisms is beginning to emerge. In this review, we discuss two major lines of genetics studies on type I IFN pathway related to human SLE: (1) expression profiling of IFN-responsive genes and (2) disease-associated SNPs of IFN-related genes, especially IRF5 (IFN-regulatory factor 5). Lastly, we discuss how such genetic alterations in type I IFN pathway fit in the current model of SLE pathogenesis.
Similar articles
-
Systemic lupus erythematosus: all roads lead to type I interferons.Curr Opin Immunol. 2006 Dec;18(6):676-82. doi: 10.1016/j.coi.2006.09.014. Epub 2006 Oct 2. Curr Opin Immunol. 2006. PMID: 17011763 Review.
-
The genetics and biology of Irf5-mediated signaling in lupus.Autoimmunity. 2007 Dec;40(8):591-601. doi: 10.1080/08916930701510905. Autoimmunity. 2007. PMID: 18075793 Review.
-
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010. Immunity. 2006. PMID: 16979570 Review.
-
Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.Ann N Y Acad Sci. 2005 Dec;1062:242-51. doi: 10.1196/annals.1358.027. Ann N Y Acad Sci. 2005. PMID: 16461805 Review.
-
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.Clin Immunol. 2008 Oct;129(1):40-8. doi: 10.1016/j.clim.2008.06.004. Epub 2008 Aug 5. Clin Immunol. 2008. PMID: 18684674
Cited by
-
Association of the CTLA-4 1722TC polymorphism and systemic lupus erythematosus: a systematic review and meta analysis.Med J Islam Repub Iran. 2014 Nov 19;28:132. eCollection 2014. Med J Islam Repub Iran. 2014. PMID: 25694990 Free PMC article. Review.
-
Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10154-9. doi: 10.1073/pnas.1005599107. Epub 2010 May 17. Proc Natl Acad Sci U S A. 2010. PMID: 20479222 Free PMC article.
-
Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.Arthritis Res Ther. 2014 Aug 8;16(4):R165. doi: 10.1186/ar4681. Arthritis Res Ther. 2014. PMID: 25107306 Free PMC article.
-
Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases.Mol Biol Rep. 2011 Oct;38(7):4663-72. doi: 10.1007/s11033-010-0601-5. Epub 2010 Dec 8. Mol Biol Rep. 2011. PMID: 21140222
-
Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.Clin Exp Immunol. 2014 Dec;178(3):428-37. doi: 10.1111/cei.12429. Clin Exp Immunol. 2014. PMID: 25130328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
